FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156592372> ?p ?o ?g. }

• W2156592372 endingPage "8855" @default.
• W2156592372 startingPage "8845" @default.
• W2156592372 abstract "Transcriptionally controlled oncolytic adenovirus CG5757 is engineered with two tumor-specific promoters from E2F-1 and human telomerase reverse transcriptase genes. This virus has broad anticancer spectrum and higher specificity. The objective of the current study is to show its antitumor selectivity and therapeutic potential.The antitumor specificity of E2F-1 and human telomerase reverse transcriptase promoters was evaluated in a panel of tumor and normal cells. Under the control of these promoters, the tumor-selective expression of E1a and E1b genes was evaluated. Further in vitro antitumor specificity and potency of this virus were characterized by viral replication and cytotoxicity assays followed by a newly developed ex vivo tumor culture assay. Subsequently, in vivo antitumor efficacy and toxicology studies were carried out to assess the therapeutic potential of this oncolytic agent.In a broad panel of cells, E2F-1 and human telomerase reverse transcriptase promoters were activated in a tumor-selective manner. Under the control of these promoters, expression of E1a and E1b genes appears only in tumor cells. This specificity is extended to viral replication and hence the cytotoxicity in a broad range of cancer cells. Furthermore, CG5757 only replicates in cancer tissues but not in normal tissues that are derived from clinical biopsies. The safety profile was further confirmed in in vivo toxicology studies, and strong efficacy was documented in several tumor xenograft models after CG5757 was given via different routes and regimens.CG5757 has strong antitumor selectivity and potency. It has low toxicity and has great potential as a therapeutic agent for different types of cancers." @default.
• W2156592372 created "2016-06-24" @default.
• W2156592372 creator A5012838289 @default.
• W2156592372 creator A5015808361 @default.
• W2156592372 creator A5018871288 @default.
• W2156592372 creator A5032016742 @default.
• W2156592372 creator A5034982418 @default.
• W2156592372 creator A5042115298 @default.
• W2156592372 creator A5052584121 @default.
• W2156592372 creator A5054396738 @default.
• W2156592372 creator A5068187592 @default.
• W2156592372 creator A5072447220 @default.
• W2156592372 creator A5076343086 @default.
• W2156592372 date "2005-12-15" @default.
• W2156592372 modified "2023-09-27" @default.
• W2156592372 title "Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models" @default.
• W2156592372 cites W1486122524 @default.
• W2156592372 cites W1632349675 @default.
• W2156592372 cites W1987052527 @default.
• W2156592372 cites W1987415144 @default.
• W2156592372 cites W1998492363 @default.
• W2156592372 cites W2000208656 @default.
• W2156592372 cites W2003114260 @default.
• W2156592372 cites W2005982240 @default.
• W2156592372 cites W2008405084 @default.
• W2156592372 cites W2013963208 @default.
• W2156592372 cites W2015967163 @default.
• W2156592372 cites W2017989250 @default.
• W2156592372 cites W2029080338 @default.
• W2156592372 cites W2034277114 @default.
• W2156592372 cites W2055406104 @default.
• W2156592372 cites W2057072329 @default.
• W2156592372 cites W2063719609 @default.
• W2156592372 cites W2065354528 @default.
• W2156592372 cites W2069058535 @default.
• W2156592372 cites W2081282586 @default.
• W2156592372 cites W2094185619 @default.
• W2156592372 cites W2101064494 @default.
• W2156592372 cites W2121790935 @default.
• W2156592372 cites W2127573529 @default.
• W2156592372 cites W2130175400 @default.
• W2156592372 cites W2145305345 @default.
• W2156592372 cites W2147039165 @default.
• W2156592372 cites W2149139293 @default.
• W2156592372 cites W2155127143 @default.
• W2156592372 cites W2156653943 @default.
• W2156592372 cites W2157882031 @default.
• W2156592372 cites W2211209526 @default.
• W2156592372 cites W2256756668 @default.
• W2156592372 cites W2319730502 @default.
• W2156592372 cites W2333464935 @default.
• W2156592372 cites W2418447573 @default.
• W2156592372 cites W4211261801 @default.
• W2156592372 doi "https://doi.org/10.1158/1078-0432.ccr-05-1757" @default.
• W2156592372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16361574" @default.
• W2156592372 hasPublicationYear "2005" @default.
• W2156592372 type Work @default.
• W2156592372 sameAs 2156592372 @default.
• W2156592372 citedByCount "23" @default.
• W2156592372 countsByYear W21565923722012 @default.
• W2156592372 countsByYear W21565923722013 @default.
• W2156592372 countsByYear W21565923722014 @default.
• W2156592372 countsByYear W21565923722016 @default.
• W2156592372 countsByYear W21565923722017 @default.
• W2156592372 countsByYear W21565923722020 @default.
• W2156592372 countsByYear W21565923722021 @default.
• W2156592372 countsByYear W21565923722023 @default.
• W2156592372 crossrefType "journal-article" @default.
• W2156592372 hasAuthorship W2156592372A5012838289 @default.
• W2156592372 hasAuthorship W2156592372A5015808361 @default.
• W2156592372 hasAuthorship W2156592372A5018871288 @default.
• W2156592372 hasAuthorship W2156592372A5032016742 @default.
• W2156592372 hasAuthorship W2156592372A5034982418 @default.
• W2156592372 hasAuthorship W2156592372A5042115298 @default.
• W2156592372 hasAuthorship W2156592372A5052584121 @default.
• W2156592372 hasAuthorship W2156592372A5054396738 @default.
• W2156592372 hasAuthorship W2156592372A5068187592 @default.
• W2156592372 hasAuthorship W2156592372A5072447220 @default.
• W2156592372 hasAuthorship W2156592372A5076343086 @default.
• W2156592372 hasBestOaLocation W21565923721 @default.
• W2156592372 hasConcept C101762097 @default.
• W2156592372 hasConcept C104317684 @default.
• W2156592372 hasConcept C109316439 @default.
• W2156592372 hasConcept C111599444 @default.
• W2156592372 hasConcept C121608353 @default.
• W2156592372 hasConcept C125593758 @default.
• W2156592372 hasConcept C150194340 @default.
• W2156592372 hasConcept C150903083 @default.
• W2156592372 hasConcept C202751555 @default.
• W2156592372 hasConcept C207001950 @default.
• W2156592372 hasConcept C2777283488 @default.
• W2156592372 hasConcept C3020616263 @default.
• W2156592372 hasConcept C49744831 @default.
• W2156592372 hasConcept C502942594 @default.
• W2156592372 hasConcept C54355233 @default.
• W2156592372 hasConcept C55493867 @default.
• W2156592372 hasConcept C82210918 @default.
• W2156592372 hasConcept C86803240 @default.

• next